...VMED O2 has positive medium-term revenue prospects related to market and convergence benefits. S&P Global Ratings expects VMED O2 to transition back to revenue growth in 2022, supported by several factors. These include reduced pressure on the average revenue per user (ARPU) from end-of-contract notifications, since existing customers have already gone through the initial notification and downward repricing process. In addition, we see some recovery in roaming revenue as travel, including for business, gradually resumes. We expect price increases to help offset promotional pricing pressure in the market. We see scope for cross-...